Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • Member Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

Chelation Partners Presents Data on Their Lead Non-Antibiotic Anti-Infective Compound at the 2018 Kansas City Animal Health Investment Forum

by administrator | Sep 13, 2018 | Chelation Partners, News

Halifax company fighting antibiotic-resistant superbugs

by administrator | Aug 30, 2017 | Chelation Partners, News

Link to original story here A Halifax company is testing a new chemical compound that acts like a magnet to break down the defences of antibiotic-resistant superbugs by depriving them of the one thing they all need — iron. Chelation Partners Inc. has been working for...

Recent Posts

  • Scotiaderm receive new funding from Natural Products Canada
  • Two people cooking in kitchen
    Province Awards Nova Scotia Lighthouse Project Funding
  • 3DBioFibR Inc. fibers being pulled
    3DBioFibR Raises $3M to Advance Next-Gen Biopolymer Fiber Manufacturing Platform
  • Logo of XO Technology
    XO Technology selected for Invest Nova Scotia’s Accelerate program
  • Establishing Canada’s first large-scale bioinnovation centre
No comments to show.

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow